Dana Farber Cancer Institute

  Dana Farber Cancer Institute (dfci), founded in 1947 and located in Changmu medical park, Boston, is a Cancer Hospital Affiliated to the teaching of Harvard Medical School and a comprehensive cancer center designated by the federal government. The adult oncology specialty of Dana Farber Cancer Institute ranks among the top hospitals in the United States over the years, and the treatment of children's tumors ranks among the top in the United States over the years (U.S. News and World Report). The Institute has been certified by the cancer diagnosis and Treatment Quality Initiative (a subsidiary of the American Clinical Cancer Association) for three consecutive years due to the high-quality cancer care services of the outpatient hematology oncology department.

  The Danner Farber Cancer Institute has been working closely with Brigham and women's Hospital (Harvard University affiliated university hospital). In 1996, the world high quality cancer institute and the world quality hospital established the Danner Farber / Bragan cancer center, and set up 12 cancer specialties integrating medical treatment, surgery, radiotherapy and new clinical trials, including treatment of lung cancer, breast cancer, and Gastric cancer, esophageal cancer, colorectal cancer, liver cancer, pancreatic cancer, leukemia, multiple myeloma, nervous system tumors, prostate cancer, kidney cancer, cervical cancer, osteosarcoma, head and neck cancer, skin cancer, melanoma and other tumor diseases. The two institutions are connected by an overpass. The outpatient service of cancer patients is generally carried out at Dana Farber Cancer Institute, while the inpatient treatment is carried out at bregen and women's hospital. From August to October 2016, Dana Farber, bregan and women's cancer center were rated as the best cancer care center in New England for the 16th consecutive year, ranking fourth in the United States.

  At present, Dana Farber Cancer Research Institute has nearly 4000 medical and nursing personnel, providing treatment to 300000 tumor patients every year, cooperating with many international well-known research institutions and medical centers, participating in more than 700 clinical trials, and carrying out a large number of research on new cancer drugs and new treatment methods. Remarkable achievements have been made in cancer gene mapping therapy, cancer immunotherapy, cancer endocrine therapy, cancer biotherapy, cancer vaccine and other clinical aspects.

  Its milestones include:

  · The test of ovarian cancer biomarker CA-125 was developed;

  · Take the lead in evaluating new methods for the treatment of prostate cancer;

  · Developed advanced brain surgery and tumor surgery technology;

  · First, the liver was treated with selective internal radiotherapy.

  The treatment team of the center is jointly established by pathology scientists, oncology experts, radiology experts, surgeons and other health care personnel. They formulate personalized treatment plans according to each patient and their disease characteristics. For local sarcoma, they can be cured by a combination of surgery, chemotherapy and radiotherapy; For patients with advanced sarcoma or metastasis, the center has also carried out a large number of clinical trials to provide treatment methods for soft tissue sarcoma and malignant osteoma (such as osteosarcoma), in order to improve the treatment effect as much as possible, reduce the recurrence rate and improve the quality of life of patients.

  Dana Faber institute not only strengthens the understanding, diagnosis, treatment, cure and prevention of cancer and related diseases, but also provides professional and considerate care for cancer children and adults. The Institute has developed many projects to promote public health, especially those at high risk and low service level. At the same time, it can also disseminate innovative treatment methods, new scientific research achievements and new drugs to target groups in the United States and even around the world.

  Sarcoma and bone tumor treatment center

  The main tumors treated by the treatment center include angiosarcoma, bone cancer, chondrosarcoma, endometrial sarcoma, osteosarcoma, synovial sarcoma, uterine sarcoma and other tumor diseases. The center is dedicated to the pathological and imaging diagnosis of sarcoma, the application of new soft tissue and bone reconstruction techniques, and the research of new treatment methods.

  Dr. Demetri, director of Dana Faber Cancer Institute's sarcoma and bone tumor treatment center, director of Dana Faber / Harvard Cancer Center's Ludwig center, executive director of Ludwig Cancer Institute's clinical transformation research center, and professor of medicine at Harvard Medical School. He is good at the treatment of soft tissue sarcoma, osteosarcoma and gastrointestinal stromal tumor.

  Dr. George is the clinical director and senior physician of the center for sarcoma and bone tumor treatment at Dana Farber Cancer Institute and an associate professor of medicine at Harvard Medical School. Clinical expertise: soft tissue sarcoma, osteosarcoma, gastrointestinal stromal tumor.

  Dr. Thornton is a doctor in the sarcoma and bone tumor treatment center of Dana Farber Cancer Institute. He has obtained the professional certification of internal medicine at Brown University Medical Center and the certification of internal medicine of tumor at Sidney Kimmel Cancer Center of Johns Hopkins Medical School. His clinical specialty is sarcoma.

More information, please pay attention to EVO WeChat official account.

Pre:McLean Hospital

Next:Massachusetts Eye and Ear Hospital